---
$id: https://graph.org.ai/products/commodity/51282919
$type: Product
source: UNSPSC
code: "51282919"
title: "Flumequine"
class: "51282900"
classTitle: "Quinolone antibacterials"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Flumequine

**UNSPSC Code**: 51282919
**Class**: [Quinolone antibacterials](Quinolone antibacterials.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a quinolone antibiotic with the molecular formula C14H12FNO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UVG8VSP2SJ, chemically known as 6,7-dihydro-9-fluoro-5-methyl-1-oxo-1h,5h-quinolizine-2-carboxylic acid but generally known as flumequine, which bears US NIH Compound Identifier 3374. European Medicines Agency schedules Flumequine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07696MIG. The term FLUMEQUINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, No. 10 1976, List 16). World Health Organization schedules flumequine in its Anatomical Therapeutic Chemical (ATC) Classification. FLUMEQUINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule flumequine under HS 29339990 and SITC 51577. As of Q4 2014, FLUMEQUINE remains the US FDA Preferred Term for this commodity. Flumequine bears US NLM identifiers UMLS ID C0060493 and NCI Concept Code C80639. SMILES: FC1CC2CCC(N3C2C(C(=O)C(C3)C(=O)O)C1)C.

